Elevance Health (ELV) Revenue — Quarter Ended Mar 31, 2024
Revenue for the quarter was essentially flat compared to the immediately preceding quarter, edging slightly lower. On a year-over-year basis, revenue increased modestly.
Key takeaway
Quarter ended Mar 31, 2024 · FY2024 Q1
Revenue for the quarter was essentially flat compared to the immediately preceding quarter, edging slightly lower. On a year-over-year basis, revenue increased modestly.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$42.6B
Revenue reported for this quarter.
Quarter-over-quarter
-0.2%
Change from the immediately preceding quarter.
Year-over-year
+1.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$171.7B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2023 | $43.7B | +13.0% |
| Sep 30, 2023 | $42.8B | +7.3% |
| Dec 31, 2023 | $42.6B | +6.8% |
| Mar 31, 2024 | $42.6B | +1.0% |
Revenue performance
Reported revenue was nearly unchanged from the prior quarter, reflecting a small decline. The year-over-year comparison shows a slight improvement.
Quarterly comparison
Revenue was higher than the same quarter one year earlier. However, it decreased slightly from the immediately preceding quarter.
What to watch
The year-over-year revenue growth rate has decelerated from higher levels seen in earlier quarters of the fiscal year.